MENU
IPA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ImmunoPrecise Antibodies (IPA) Ownership - Who owns ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies Ltd is a biotherapeutic research and technology firm... Show more
Profile
Industry
N/A
Address
3204 - 4464 Markham Street
Phone
+1 701 404-1043
Employees
102
Web
https://www.immunoprecise.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.91M
P/E Ratio
N/A
Total Cash
12.92M
Projected Growth
N/A
Total Debt
12.93M
Revenue
24M
Risk (Beta)
-0.01
Dividend Yield
N/A
Total Cash/Share
0.28
Total Debt/Equity
N/A
Revenue/Share
0.60 USD as % of share price
Fundamentals
IPA
Capitalization
19.9M
P/E Ratio
N/A
Risk (Beta)
-0.01
Dividend Yield
N/A
Total Cash
12.9M
Total Cash/Share
0.28
Total Debt
12.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.60%
Revenue
24M
ROE
N/A
Book Value
25.1M
P/B Ratio
1.10
Cash Flow
N/A
Earnings
-1.68
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
136M
Current Ratio
2.32
Current Revenue Per Employee
60900.99
Dividends Per Share - Security
N/A
EBITDA
-45.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.57
Revenue To Assets
-75.26
Shares Held By Institutions
803K
Shares Outstanding - Current
45.8M
Total Liabilities
20.4M
Total Volume MTD
N/A
Value
1
Gain YTD
7.846
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3204 - 4464 Markham Street
Phone
+1 701 404-1043
Employees
102
Web
https://www.immunoprecise.com